Biology Reference
In-Depth Information
8. Bruns RF. (1980) Adenosine receptor activation in human fibroblasts: nucleoside agonists and
antagonists. Can J Physiol Pharmacol 58:673-91.
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M,
Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau
W, Nagy A. (1996) Abnormal blood vessel development and lethality in embryos lacking a
single VEGF allele. Nature 380:435-9.
10. Cassada DC, Tribble CG, Laubach VE, Nguyen BN, Rieger JM, Linden J, Kaza AK,
Long SM, Kron IL, Kern JA. (2001) An adenosine A2A agonist, ATL-146e, reduces paralysis
and apoptosis during rabbit spinal cord reperfusion. J Vasc Surg 34:482-8.
11. Chen H, Yang D, Carroll SH, Eltzschig HK, Ravid K. (2009) Activation of the macrophage
A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury.
Exp Hematol 37:533-8.
12. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z,
Rockson SG, van de Rijn M, Botstein D, Brown PO. (2003) Endothelial cell diversity revealed
by global expression profiling. Proc Natl Acad Sci USA 100:10623-8.
13. Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH,
Ratcliffe PJ, Maher ER. (2001) Contrasting effects on HIF-1alpha regulation by disease-
causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau
disease. Hum Mol Genet 10:1029-38.
14. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y,
Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D,
Carmeliet P. (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation,
whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med
8:702-10.
15. Daly JW, Padgett WL. (1992) Agonist activity of 2- and 5
-substituted adenosine analogs
and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate
cyclase. Biochem Pharmacol 43:1089-93.
16. Desai A, Victor-Vega C, Gadangi S, Montesinos MC, Chu CC, Cronstein BN. (2005)
Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production
of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol 67:1406-13.
17. Duan LJ, Zhang-Benoit Y, Fong GH. (2005) Endothelium-intrinsic requirement for Hif-2alpha
during vascular development. Circulation 111:2227-32.
18. Dubey RK, Gillespie DG, Jackson EK. (2002) A(2B) adenosine receptors stimulate growth of
porcine and rat arterial endothelial cells. Hypertension 39:530-5.
19. Eckle T, Grenz A, Laucher S, Eltzschig HK. (2008) A2B adenosine receptor signaling
attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest
118:3301-15.
20. Eltzschig HK, Kohler D, Eckle T, Kong T, Robson SC, Colgan SP. (2009) Central role of
Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113:224-32.
21. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, Loffler M, Reyes
G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP. (2005) HIF-
1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med
202:1493-505.
22. Ethier MF, Dobson JG, Jr. (1997) Adenosine stimulation of DNA synthesis in human
endothelial cells. Am J Physiol 272:H1470-9.
23. Ethier MF, Chander V, Dobson JG, Jr. (1993) Adenosine stimulates proliferation of human
endothelial cells in culture. Am J Physiol 265:H131-8.
24. Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I. (2003) Mast cell-mediated stimulation
of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ Res
92:485-92.
25. Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-Yasenetskaya T,
Biaggioni I. (2002) Differential expression of adenosine receptors in human endothelial cells:
role of A2B receptors in angiogenic factor regulation. Circ Res 90:531-8.
Search WWH ::
Custom Search